Contact lenses

Founded in 1987, Canaan has $2.4 billion capital under management and has invested in more than 240 companies, completed 63 mergers and acquisitions, and brought over 50 companies public.

The firm's healthcare team is committed to catalyzing the development of biotechnology, medical device, diagnostic and therapeutics companies that are revolutionizing the practice of medicine.

Among its recent successes are Dexcom Inc., the largest diagnostic IPO of 2006, and Cerexa Inc., the largest private biotech merger and acquisition in history.

Other recent Canaan healthcare investments include Chimerix, Coapt, CoAxia and Northstar Neuroscience (NSTR).

Canaan is headquartered in Menlo Park, California and also has offices in Connecticut, India and Israel.

For more information visit: www.canaan.com.

About Domain Associates Founded in 1985, Domain Associates, L.L.C.

is a venture capital firm with an exclusive focus on life sciences.

With $2.1 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.

Domain's three major investment segments are pharmaceuticals,...

Read more...